Suchergebnisse

Introduction:
The spread of coronavirus disease (COVID-19) is a new public health concern that has shaken the whole world and possesses a challenge to the mental health of the public. This study aimed to investigate the impact of COVID-19 pandemic on the perceived stress, anxiety level, and mental health of medical students as well as to explore the knowledge of COVID-19 among Indian medical students.


Methods:
A web-based cross-sectional survey was conducted among the undergraduate medical interns and postgraduate medical residents using the online data collection form. The form consisted of five domains (sociodemographic details, knowledge assessment, perceived stress assessment, generalized anxiety disorder-7 assessment, and assessment of the perceived level of change in social habits and personal hygiene related to COVID-19 outbreak). The statistical analysis of the responses was carried out by the Mann–Whitney U-test and Kruskal–Wallis tests.


Results:
Two hundred participants filled the distributed survey, 61% (n = 122) were males. The mean knowledge score of 200 participants was 4.27 ± 1.45. The participant had a mean perceived stress score of 18.35 ± 6.28, and the females had a significantly higher perceived stress level than the male (P = 0.037). About 10% (n = 20) of the participants reported high perceived stress level (27–40), and moderate stress (score 14–26) was reported in 69% (n = 138) of the participants. However, only 21% (n = 42) of the participants reported low stress (0–13). While only moderate anxiety (score 10–14) was reported in 16% (n = 32) of the participant and 4% (n = 8) of the participants reported severe anxiety (score >14).


Conclusion:
There is an increased stress and anxiety in Indian medical students due to overburdened responsibilities and lack of adequate resources.

Background: Older people often receive multiple medications for chronic conditions, which often result in polypharmacy (concomitant use of 5‒9 medicines) and hyperpolypharmacy (concomitant use of ≥10 medicines). A limited number of studies have been performed to evaluate the prevalence of polypharmacy, hyperpolypharmacy, and potentially inappropriate medication (PIM) use in older people of developing countries. The present study aimed to investigate regional variations in the prevalence of polypharmacy, hyperpolypharmacy, and PIM use in older people (60 + years) in India. Methods: Studies were identified using Medline/PubMed, Scopus, and Google Scholar databases published from inception (2002) to September 31, 2020. Out of the total 1890 articles, 27 were included in the study. Results: Overall, the pooled prevalence of polypharmacy was 49% (95% confidence interval: 42–56; p < 0.01), hyperpolypharmacy was 31% (21–40; p < 0.01), and PIM use was 28% (24–32; p < 0.01) among older Indian adults. Polypharmacy was more prevalent in North-east India (65%, 50–79), whereas hyperpolypharmacy was prevalent in south India (33%, 17–48). Region-wize estimates for the pooled prevalence of PIM use in India were as follows: 23% (21–25) in East, 33% in West (24–42), 17.8% in North (11–23), and 32% (26–38) in South India. The prevalence of PIM use in adults aged ≥70°years was 35% (28–42), in those taking more medications (≥5.5/day) was 27% (22–31), and in adults using a high number of PIMs (≥3) was 29% (22–36). Subgroup analysis showed that cross-sectional studies had a higher pooled prevalence of polypharmacy 55% (44–65) than cohorts 45% (37–54). Hyperpolypharmacy in inpatient care settings was 37% (26–47), whereas PIM use was higher in private hospitals 31% (24–38) than government hospitals 25% (19–31). Conclusion: Polypharmacy and hyperpolypharmacy are widely prevalent in India. About 28% of older Indian adults are affected by PIM use. Thus, appropriate steps are needed to promote rational geriatric prescribing in ...